Home » Stocks » CANB

Can B Corp (CANB)

Stock Price: $0.7600 USD 0.1000 (15.15%)
Updated Jan 15, 2021 3:41 PM EST - Market closed
Market Cap 3.41M
Revenue (ttm) 1.77M
Net Income (ttm) -4.60M
Shares Out 3.38M
EPS (ttm) -2.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $0.7600
Previous Close $0.6600
Change ($) 0.1000
Change (%) 15.15%
Day's Open 0.7200
Day's Range 0.6800 - 0.8000
Day's Volume 64,312
52-Week Range 0.0052 - 2.11

News

There are no news available yet.

About CANB

Can B produces and sells cannabidiol (CBD) based products for pain, insomnia, epilepsy, anxiety, inflammation, and nausea in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, and concentrates through its Website, and doctors and other medical professionals. It also offers document, project, marketing, and sales management systems to its residual business clients through website and proprietary software. The company was formerly known as Canbiola Inc. an... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
2005
CEO
Marco Alfonsi
Employees
17
Stock Exchange
OTCMKTS
Ticker Symbol
CANB
Full Company Profile

Financial Performance

In 2019, Can B Corp's revenue was $2.31 million, an increase of 244.82% compared to the previous year's $668,603. Losses were -$4.59 million, 11.7% more than in 2018.

Financial Statements